Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibikase Therapeutics (IKT) Cash from Investing Activities (2022 - 2026)

Inhibikase Therapeutics (IKT) has 5 years of Cash from Investing Activities data on record, last reported at -$80.5 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 482.27% to -$80.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$99.5 million, a 687.19% decrease, with the full-year FY2025 number at $2.1 million, up 105.55% from a year prior.
  • Cash from Investing Activities reached -$80.5 million in Q1 2026 per IKT's latest filing, down from -$98847.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for IKT hit a ceiling of $21.1 million in Q1 2025 and a floor of -$80.5 million in Q1 2026.
  • A 5-year average of -$7.5 million and a median of -$70968.0 in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: soared 6017.7% in 2023, then crashed 1732.19% in 2024.
  • Tracing IKT's Cash from Investing Activities over 5 years: stood at $5.0 million in 2022, then tumbled by 142.63% to -$2.1 million in 2023, then plummeted by 1732.19% to -$38.8 million in 2024, then skyrocketed by 99.74% to -$98847.0 in 2025, then crashed by 81323.4% to -$80.5 million in 2026.
  • Business Quant data shows Cash from Investing Activities for IKT at -$80.5 million in Q1 2026, -$98847.0 in Q4 2025, and -$28.7 million in Q3 2025.